Understanding fatigue and quality of life in patients with operable pancreatic tumors and diabetes
Trajectories of Fatigue, Glycated Hemoglobin, Diabetes Self-management, and Quality of Life in People With a Dual Diagnosis of Operable Pancreatic Tumor and Diabetes Mellitus: A Longitudinal Mixed-methods Study
This study looks at how fatigue and quality of life change for people with operable pancreatic tumors and diabetes over a year after surgery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 115 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06013228 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the relationships between fatigue, glycemic control, diabetes self-management, and quality of life in individuals diagnosed with operable pancreatic tumors and diabetes mellitus over a 12-month period post-surgery. It will track changes in these factors and gather qualitative insights into the experiences of patients facing these dual challenges. The study employs a longitudinal concurrent mixed methods design to provide a comprehensive understanding of how these conditions interact and affect patient well-being.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and above who have been diagnosed with an operable pancreatic tumor and diabetes mellitus.
Not a fit: Patients currently undergoing active treatment for cancers other than pancreatic tumors or those with cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for fatigue and quality of life in patients with both operable pancreatic tumors and diabetes.
How similar studies have performed: While there is limited research specifically on this dual condition, studies on fatigue in cancer patients and diabetes management have shown promising results, indicating potential for success in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Operable pancreatic tumor within 5 years and are following up at the outpatient department * Diagnosed with diabetes mellitus * Aged 18 or above * Can communicate in Mandarin or Taiwanese * Agree to participate and sign the informed consent form Exclusion Criteria: * Under active treatment for cancer other than pancreatic tumor * Have a cognitive impairment * Do not know that they have pancreatic tumor * Diagnosed with chronic fatigue syndrome or fibromyalgia
Where this trial is running
Taipei
- National Taiwan University Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Principal investigator: Hsuan-Ju Kuo, PhD — National Taiwan University
- Study coordinator: Hsuan-Ju Kuo, PhD
- Email: hsuanjukuo@ntu.edu.tw
- Phone: +886-2-23123456
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.